PIK3CA mutation trang 1 tải miễn phí từ tailieunhanh

"PIK3CA mutation" trang 1 - tải miễn phí từ tailieunhanh

Prognostic and clinical impact of PIK3CA mutation in gastric cancer: Pyrosequencing technology and literature review

Prognostic and clinical impact of PIK3CA mutation in gastric cancer: Pyrosequencing technology and literature review

8 32 1

Identification of PIK3CA multigene mutation patterns associated with superior prognosis in stomach cancer

Identification of PIK3CA multigene mutation patterns associated with superior prognosis in stomach cancer

15 32 1

PIK3CA amplification is common in left side tubular adenomas but uncommon sessile serrated adenomas exclusively with KRAS mutation

PIK3CA amplification is common in left side tubular adenomas but uncommon sessile serrated adenomas exclusively with KRAS mutation

5 77 0

Everolimus in hormone receptor-positive metastatic breast cancer: PIK3CA mutation H1047R was a potential efficacy biomarker in a retrospective study

Everolimus in hormone receptor-positive metastatic breast cancer: PIK3CA mutation H1047R was a potential efficacy biomarker in a retrospective study

9 91 0

Different associations of tumor PIK3CA mutations and clinical outcomes according to aspirin use among women with metastatic hormone receptor positive breast cancer

Different associations of tumor PIK3CA mutations and clinical outcomes according to aspirin use among women with metastatic hormone receptor positive breast cancer

10 72 0

$Prospective phase II trial of everolimus in PIK3CA amplification/mutation and/or PTEN loss patients with advanced solid tumors refractory to standard therapy$

Prospective phase II trial of everolimus in PIK3CA amplification/mutation and/or PTEN loss patients with advanced solid tumors refractory to standard therapy

6 27 1

Investigation of exon20 PIK3CA gene mutation in plasma of hormone receptor positive breast cancer patients

Investigation of exon20 PIK3CA gene mutation in plasma of hormone receptor positive breast cancer patients

9 1 1

Retrospective study of RAS/PIK3CA/BRAF tumor mutations as predictors of response to first-line chemotherapy with bevacizumab in metastatic colorectal cancer patients

Retrospective study of RAS/PIK3CA/BRAF tumor mutations as predictors of response to first-line chemotherapy with bevacizumab in metastatic colorectal cancer patients

9 50 1

BRAF V600E mutation and KRAS codon 13 mutations predict poor survival in Chinese colorectal cancer patients

BRAF V600E mutation and KRAS codon 13 mutations predict poor survival in Chinese colorectal cancer patients

12 38 1

Single cell mutational analysis of PIK3CA in circulating tumor cells and metastases in breast cancer reveals heterogeneity, discordance, and mutation persistence in cultured disseminated tumor cells from bone marrow

Single cell mutational analysis of PIK3CA in circulating tumor cells and metastases in breast cancer reveals heterogeneity, discordance, and mutation persistence in cultured disseminated tumor cells from bone marrow

12 41 1

Prospective genetic profiling of squamous cell lung cancer and adenosquamous carcinoma in Japanese patients by multitarget assays

Prospective genetic profiling of squamous cell lung cancer and adenosquamous carcinoma in Japanese patients by multitarget assays

7 71 1

Successful control of heavily pretreated metastatic gastric cancer with the mTOR inhibitor everolimus (RAD001) in a patient with PIK3CA mutation and pS6 overexpression

Successful control of heavily pretreated metastatic gastric cancer with the mTOR inhibitor everolimus (RAD001) in a patient with PIK3CA mutation and pS6 overexpression

6 31 1

PIK3CA mutation is a favorable prognostic factor in esophageal cancer: Molecular profile by next-generation sequencing using surgically resected formalin-fixed, paraffin-embedded tissue

13 87 0

PIK3CA mutation status, progression and survival in advanced HR+/HER2- breast cancer: A meta-analysis of published clinical trials

PIK3CA mutation status, progression and survival in advanced HR+/HER2- breast cancer: A meta-analysis of published clinical trials

11 1 1